India Glycols Q1 FY27: PAT up 45% YoY at Rs 76.6 cr, revenue rises 19%
INDIAGLYCO · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 1.0 pts more than Nifty Microcap 250 and 0.9 pts more than its Breweries & Distilleries peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
India Glycols posted Q1 FY27 standalone revenue of Rs 2,986.92 cr, up 19.3% YoY from Rs 2,503.03 cr. PAT surged 44.9% to Rs 76.59 cr vs Rs 52.85 cr, with EPS at Rs 11.43 vs Rs 8.53. EBITDA rose to Rs 170.30 cr from Rs 149.26 cr. Potable Spirits drove revenue at Rs 2,218.67 cr. NCLT sanctioned the demerger of Bio Pharma and Spirits & Biofuel undertakings on July 17, 2026.
Strong quarterly earnings with sharp PAT growth; demerger scheme sanctioned by NCLT may unlock value in upcoming listings.